Article
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brain : a journal of neurology - 21 Nov 2022
Brunklaus Andreas, Brünger Tobias, Feng Tony, Fons Carmen, Lehikoinen Anni, Panagiotakaki Eleni, Vintan Mihaela-Adela, Symonds Joseph, Andrew James, Arzimanoglou Alexis, Delima Sarah, Gallois Julie, Hanrahan Donncha, Lesca Gaetan, MacLeod Stewart, Marjanovic Dragan, McTague Amy, Nuñez-Enamorado Noemi, Perez-Palma Eduardo, Scott Perry M, Pysden Karen, Russ-Hall Sophie J, Scheffer Ingrid E, Sully Krystal, Syrbe Steffen, Vaher Ulvi, Velayutham Murugan, Vogt Julie, Weiss Shelly, Wirrell Elaine, Zuberi Sameer M, Lal Dennis, Møller Rikke S, Mantegazza Massimo, Cestèle Sandrine
Abstract excerpt
Brain voltage-gated sodium channel NaV1.1 (SCN1A) loss-of-function variants cause the severe epilepsy Dravet syndrome, as well as milder phenotypes associated with genetic epilepsy with febrile seizures plus. Gain of function SCN1A variants are associated with familial hemiplegic migraine type 3. Novel SCN1A-related phenotypes have been described including early infantile developmental and epileptic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
